Why Some Breast Cancers Grow Fast, and Some Do Not (Understand Your Reports)

You’ve probably been up late googling. Maybe you just got your biopsy results, or your sister did, or your mother. And you’re seeing all these terms – receptors, grades, HER2, and none of it makes sense. 

Worse, you might have heard someone say “Oh, hers is slow-growing, she’ll be fine” while your doctor used words like “aggressive” about yours.

I understand it. You’re scared. You want answers. As a breast cancer specialist in Nagpur, I have seen many patients coming up with the same queries. Today, I wish to guide you about it through my blog. Still, if you have any questions, feel free to reach out to me. I’ll try my best to help you out. 

Remember this before we proceed.

While the cancer type (ER/PR/HER2 status) tells us what “fuel” the cancer uses and the grade (1, 2, or 3) tells us how fast the cells are dividing, genetic mutations explain why the cells are behaving that way and reveal specific vulnerabilities we can target. This is what I typically look at while doing breast cancer treatment in Nagpur.

What Are Hormone Receptors and Why Do They Matter in Breast Cancer?

Before we talk about cancer, let’s talk about us. Our body.

Our entire body is made up of billions of tiny cells. These cells group together to form tissues. Our skin is a tissue; our heart is made of tissue; and yes, our breasts are tissue, too. 

Just like every other part of your body, our breast tissue is alive. It’s not just sitting there; it’s constantly responding to the hormones our bodies produce, especially estrogen and progesterone.

These hormones are messengers. Think of them as letters delivered to your breast cells.

Now, for these “letters” to be read, your cells need a “mailbox,” something that can receive and read the message. We call these mailboxes “receptors.” They sit on the surface of your cells, waiting for hormones to arrive.

In everyday life, when estrogen shows up and finds its receptor, it tells your breast cells things like “time to prepare for possible pregnancy” or “help maintain breast tissue.” This is completely normal. Every woman has these receptors. They’re supposed to be there.

How Hormone Receptors Affect Breast Cancer Growth Rate

So what exactly happens when cancer develops? Where do these “cancer cells” even come from?

Here’s the truth: cancer cells are your own cells that went wrong. They’re not invaders from outside. They started as normal breast cells, the same cells with those hormone receptors we just talked about.

Every day, your cells divide to replace old or damaged cells. It’s normal. But during this copying process, mistakes sometimes occur in the DNA, the instruction manual inside each cell. Most of the time, your body catches these mistakes and either repairs the damaged cell or destroys it entirely.

But occasionally, the right combination of mistakes happens in the wrong genes – genes that control cell growth and division. 

When that happens, a cell stops following the normal rules. 

It doesn’t stop dividing when it should. It doesn’t die when it’s supposed to. It just keeps multiplying, creating more and more abnormal cells.

That’s cancer. It’s your own breast cells that have accumulated enough genetic damage that they’ve become rogue.

Now here’s the interesting part: because cancer cells started as your normal breast cells, many of them still have those same hormone receptors we talked about, those “mailboxes” for estrogen and progesterone.

Some cancer cells keep these receptors. Some lose them as they become more abnormal. And this, believe it or not, makes a huge difference in how your cancer behaves and how we treat it.

Let me explain why.

Classifications of breast cancer based on specific proteins (receptors) on cancer cells

ER-Positive and PR-Positive Breast Cancer: Why They Grow Slower

About 7 out of 10 women with breast cancer have what we call “ER-positive” or “PR-positive” (or both) cancer. This means the cancer cells still have those estrogen and progesterone receptors – those mailboxes we talked about.

Now, you might think, “Wait, if estrogen makes my cancer grow, isn’t that terrible?” I understand why you’d think that. But here’s the thing: because we know what’s feeding your cancer, we can starve it.

These cancers genuinely need estrogen to thrive. It’s like they’re addicted to it. Without estrogen, they slow way down, sometimes almost to a crawl. Studies show these cancers can take over a year just to double in size (around 16 months, to be specific). That’s why we have time to think, to plan, to get second opinions if you need them.

And here’s the real good news: we have pills that block estrogen. Not chemotherapy, just pills. Many of my patients take them once a day for five to ten years, and they go on living completely normal lives. They work, travel, take care of their grandchildren, and return to their jobs. The side effects can be annoying, hot flashes and joint aches for some, but we’re talking about pills, not IV chemotherapy that makes your hair fall out.

I’ve watched women with ER-positive breast cancer celebrate 10, 15, 20 years cancer-free on these medications. This is good biology to have, even though I know “good” and “cancer” don’t seem like they belong in the same sentence.

HER2-Positive Breast Cancer: Understanding Aggressive Growth

HER2 Positive Breast Cancer How It Differs from Normal Cells

About 1 in 5 breast cancers have something different going on. These cancers have too many copies of the HER2 receptor.

You know how normal cells know when to stop growing? They have signals that say, “Okay, that’s enough, take a break.” HER2 is one of those growth signals, but when there’s too much of it, it’s like someone’s holding down the accelerator. The cancer cells just keep getting the message to grow, grow, grow. The cancerous cells don’t stop growing. 

These cancers can double in size in about six months. I won’t sugarcoat it; that’s fast. And 15 years ago, before we had the treatments we have now, HER2-positive cancer was the type every doctor worried about most.

But something remarkable happened. Scientists developed drugs that target HER2 specifically. The most famous is called Herceptin or trastuzumab, as we know it. As the research is evolving, we also have something called pertuzumab, which adds to the benefit of Herceptin. These drugs are like precision missiles; they home in on the HER2 protein and essentially jam the signal. The cancer’s growth slams on the brakes.

I have patients who were diagnosed with HER2-positive cancer a decade ago. They got their Herceptin, they got through their treatment, and they’re living whole lives now. Their kids graduated from college. They became grandmothers. This diagnosis used to be our worst nightmare, and now we have fundamental tools to fight it.

Triple-Negative Breast Cancer: Why It Grows Fastest and What That Means

Then there’s triple-negative breast cancer. About 15% of breast cancers are this type. The name tells you what it is: negative for estrogen receptors, negative for progesterone receptors, negative for HER2.

No mailboxes. Nothing for us to target with hormones or HER2 drugs.

This is the one that grows fastest. I’m not going to lie to you about that. These cancers are aggressive, and they tend to show up in younger women, and yes, they’re harder to treat because we don’t have those targeted therapies.

But please listen to me carefully: “harder to treat” does not mean “untreatable.”

Chemotherapy works on triple-negative breast cancer. Often very well. And because these cells are dividing so fast, they’re actually more vulnerable to chemotherapy than slower-growing cancers. The chemo hits them when they’re most exposed.

Triple Negative Breast Cancer Why It Grows Fast and How Treatment Targets It

We’re also using immunotherapy now, that’s pembrolizumab, you might have heard about, drugs that wake up your own immune system to fight cancer. For some women with triple-negative disease, this has been game-changing.

Is this the diagnosis anyone wants? 

No. But I’ve seen women beat it. I’ve seen them thrive afterwards. You need to know that.

Breast Cancer Grade 1, 2, and 3: How Tumour Grade Affects Growth Speed

When your tissue is sent to the lab, a pathologist examines it under a microscope. They’re asking: “How much do these cancer cells still look and act like normal breast cells?”

Normal breast cells are organised. They form neat little ducts and lobules. They know their place. They divide when they’re supposed to and stop when they’re supposed to.

Grade 1: The cancer cells still look somewhat organised. They’re making an effort to form structures. They’re dividing, but not that fast. These are the tortoises of the cancer world, slow and steady, but we can usually manage them well.

Grade 2: The cells are starting to lose their structure. They’re getting more chaotic. Growing at a moderate pace.

Grade 3: These cells have entirely lost the plot. They don’t form any typical structures. They look wild and disorganised under the microscope. And they’re dividing rapidly.

I know “Grade 3” sounds terrifying. But here’s something important: higher-grade cancers often respond better to chemotherapy. Because they’re dividing so fast, the chemotherapy catches them in the act. Lower-grade cancers can sometimes be sneakier.

We also look at something called Ki-67, which is basically a measure of what percentage of your cancer cells are actively dividing right now. In Grade 1 cancers, it might be 15%. In Grade 3, it might be 35% or higher. More division means faster growth, but also more vulnerability to treatment.

Ki 67 Score Explained What It Means for Cancer Growth and Treatment Decisions

TP53 and BRCA Mutations: How Genetic Changes Make Cancer More Aggressive

Your body has built-in safety systems to prevent cancer. Think of them as security guards patrolling your cells.

TP53: This gene’s job is to spot damaged cells and either fix them or destroy them before they can become cancerous. It’s the body’s most important tumour suppressor. But in about 30-40% of breast cancers, this gene has stopped working. The security guard fell asleep. So damaged cells that should have been eliminated keep growing.

Cancers with TP53 mutations tend to be more aggressive. They’re higher grade, they grow faster, and they’re more resistant to some treatments. If your genetic report mentions TP53, your doctor might recommend more aggressive treatment upfront.

BRCA1 and BRCA2: You’ve probably heard of these from Angelina Jolie’s story. These genes are your DNA repair crew. Every day, your cells accumulate tiny bits of DNA damage; it’s normal; it happens to everyone. BRCA genes fix that damage.

But some people inherit faulty versions of the BRCA genes, maybe from mom, maybe from dad. And when these genes don’t function, DNA damage accumulates. That’s why women with BRCA mutations have a 70-80% lifetime risk of breast cancer, and why their cancers often develop at a younger age.

Most BRCA1 breast cancers are triple-negative. They’re aggressive. But, and this is important, cancers with BRCA mutations have an Achilles’ heel. They’re exquisitely sensitive to platinum chemotherapy (like the drug carboplatin) and to newer drugs called PARP inhibitors. We’re using these genes against the cancer.

If you have a BRCA mutation, I know you’re dealing with a lot, worry about your own cancer, worry about whether you passed it to your children, worry about ovarian cancer, too. But I want you to know that we test for this specifically so we can treat you better.

How Doctors Use Cancer Type to Plan Your Breast Cancer Treatment

When you come in for your consultation, whether that’s in Mumbai, Delhi, or looking for breast cancer treatment in Nagpur, we’re going to look at your complete picture:

Understanding Your Cancer Profile Type Grade and Genetic Mutations
  • What receptors does your cancer have?
  • What grade is it?
  • How fast are the cells dividing?
  • Are there genetic mutations we can target?
  • What stage is it (how far has it spread)?

And then we build a plan specifically for your cancer.

Slow-growing, hormone-positive cancer? We might do surgery first, then put you on hormone pills for years. No chemo needed for many women in this category. The good news is, we also have tools to assess the benefit of chemotherapy in hormone-positive cancer. So next time you consult your breast specialist, don’t forget to discuss it.

HER2-positive? We’re bringing out the targeted therapy along with chemotherapy. Yes, it’s more intense, but we’re hitting it with everything we’ve got, and it works. 

Triple-negative? We’re probably talking chemotherapy upfront, maybe immunotherapy, surgery, and radiation. It’s a more challenging road, but people get through it.

Surgery is usually offered after completion of chemotherapy in HER2-positive and Triple negative breast cancers. Taking chemotherapy first helps decrease the tumor load in your body, decreases the size of the lump, thereby increasing your chances of saving the breast. Whole breast removal or mastectomy is then not done in such situations and breast conservation is easily possible.

Does Fast-Growing Breast Cancer Mean Worse Outcome? The Truth

Faster-growing cancer doesn’t automatically mean a worse outcome. I’ve seen women with aggressive triple-negative cancers go through a lot of agony with treatment but come out cancer-free and stay that way. I’ve also seen women with slow-growing ER-positive cancers that eventually became resistant to hormones and caused problems years later.

Cancer doesn’t follow a script.

What matters most isn’t just the biology of your cancer, it’s catching it, treating it appropriately, and following up carefully.

Living with Aggressive Breast Cancer: What Your Statistics Really Mean

Some of you reading this have the scary pathology. Triple-negative, high-grade, TP53-mutated. And you’re thinking, “This doctor is trying to make me feel better, but I know mine is bad.”

You’re right that yours is more aggressive. I won’t pretend otherwise. The treatment will be more complex. The statistics might be scarier.

But you need to know something: you’re not a statistic. Statistics tell us about populations, not about you specifically. I have patients who were supposed to have “bad” cancers who are thriving ten years later. And I’ve had patients with “good” cancers who struggled.

What I can promise you is that we’ll use every weapon in our arsenal for your specific cancer. Medicine has advanced so much, even in just the past five years. Clinical trials constantly test new drugs. Immunotherapy is changing the game.

De-escalating surgeries from mastectomies (the surgical removal of the entire breast) to saving breasts and just performing lumpectomies  (the removal of only the tumour and a small rim of healthy tissue) is now a reality, all thanks to the latest chemotherapy and treatment protocols available with us. This not only helps us cure your cancer, but also preserves your womanhood through advanced surgical techniques. 

Your cancer may be aggressive, but so is your oncologist.

Can You Prevent Breast Cancer, or Is It Random? Understanding Your Risk

You didn’t cause this. Don’t blame yourself even if you never exercised, or you drank wine every night, or you were on birth control for years, or you didn’t breastfeed, or you’re overweight.

Yes, these are risk factors, but not the cause of cancer.

Breast cancer develops because of random genetic mutations that accumulate over time. Sometimes there’s a hereditary component; usually there isn’t. But it’s not your fault.

Now we deal with it. Together.

You’re allowed to be scared. You’re allowed to cry. You’re allowed to be angry. And then, when you’re ready, we make a plan, and we fight.

I’ll be here through all of it. 

Latest Blogs